Testosterone amplifies excitotoxic damage of cultured oligodendrocytes

Journal of Neurochemistry

Volumn 88, Issue 5, 2004, Pages 1179-1185

  Caruso, A ^a,c   Di Giorgi Gerevini, V ^a   Castiglione, M ^a   Marinelli, F ^b   Tomassini, V ^b   Pozzilli, C ^b   Caricasole, A ^d   Bruno, V ^e   Caciagli, F ^c   Moretti, A ^a   Nicoletti, F ^e   Melchiorri, Daniela ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d Siena Biotech SpA   (Italy)

^e IRCCS NEUROMED   (Italy)

Author keywords

AMPA; Excitotoxicity; Kainate; Oligodendrocytes; Testosterone

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINOGLUTETHIMIDE; AMPA RECEPTOR; ANDROGEN RECEPTOR; AROMATASE INHIBITOR; CYCLOTHIAZIDE; EXCITOTOXIN; FORMESTANE; GLUTAMATE RECEPTOR 1; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR 6; GLUTAMATE RECEPTOR 7; KAINIC ACID; KAINIC ACID RECEPTOR; PROTEIN P53; RECEPTOR SUBUNIT; TESTOSTERONE; TESTOSTERONE ENANTATE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DEMYELINATING DISEASE; GENE AMPLIFICATION; GENE INDUCTION; HORMONE ACTION; IN VITRO STUDY; MULTIPLE SCLEROSIS; NERVE CELL CULTURE; NERVE CELL LESION; NERVE CELL NECROSIS; NONHUMAN; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; SEX DIFFERENCE;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; BENZOTHIADIAZINES; CALCIUM; CELLS, CULTURED; DRUG SYNERGISM; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GENE EXPRESSION; KAINIC ACID; L-LACTATE DEHYDROGENASE; NEUROTOXINS; OLIGODENDROGLIA; QUINOXALINES; RATS; RECEPTORS, AMPA; RECEPTORS, ANDROGEN; RECEPTORS, KAINIC ACID; TESTOSTERONE; TIME FACTORS;

ANIMALIA;

EID: 10744220639     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2004.02284.x     Document Type: Article

References (38)

1. Agresti C., D'Urso D. and Levi G. (1996) Reversible inhibitory effects of interferon-gamma and tumour necrosis factor-alpha on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur. J. Neurosci. 8, 1106-1116.
2. Alberdi E., Sanchez-Gomez M. V., Marino A. and Matute C. (2002) Ca(2+) influx through AMPA or kainate receptors alone is sufficient to initiate excitotoxicity in cultured oligodendrocytes. Neurobiol. Dis. 9, 234-243.
3. Auffray C. and Rougeon F. (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107, 303-314.
4. Burnashev N. (1996) Calcium permeability of glutamate-gated channels in the central nervous system. Curr. Opin. Neurobiol. 6, 311-317.
5. Burnashev N., Monyer H., Seeburg P. H. and Sakmann B. (1992) Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron 8, 189-198.
6. Cocconi G. (1994) First generation aromatase inhibitors: aminoglutethimide and testololactone. Breast Cancer Res. Treat. 30, 57-80.
7. Dalal M., Kim S. and Voskuhl R. R. (1997) Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159, 3-6.
8. Degli Esposti M. and Dive C. (2003) Mitochondrial membrane permeabilisation by Bax/Bak. Biochem. Biophys. Res. Commun. 304, 455-461.
9. Dubois-Dalcq M., Behar T., Hudson L. and Lazzarini R. A. (1986) Emergence of three myelin proteins in oligodendrocytes cultured without neurons. J. Cell Biol. 102, 384-392.
10. Duquette P. and Girard M. (1993) Hormonal factors in susceptibility to multiple sclerosis. Curr. Opin. Neurol. Neurosurg. 6, 195-201.
11. Enoch T. and Norbury C. (1995) Cellular responses to DNA damage. cell-cycle checkpoints, apoptosis and the roles of p53 and ATM. Trends Biochem. Sci. 20, 426-430.
12. Fern R. and Moller T. (2000) Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 1, 34-42.
13. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M. and LeBlanc A. (2001) Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77, 1319-1326.
14. Hawkins S. A. and McDonnell G. V. (1999) Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J. Neurol. Neurosurg. Psychiatry 67, 148-152.
15. Jonas P., Racca C., Sakmann B., Seeburg P. H. and Monyer H. (1994) Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron 12, 1281-1289.
16. Kim S., Liva S. M., Dalal M. A., Verity M. A. and Voskuhl R. R. (1999) Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 52, 1230-1238.
17. Ladiwala U., Li H., Antel J. P. and Nalbantoglu J. (1999) p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes. J. Neurochem. 73, 605-611.
18. Levi G., Aloisi F. and Wilkin G. P. (1987) Differentiation of cerebellar bipotential glial precursors into oligodendrocytes in primary culture: developmental profile of surface antigens and mitotic activity. J. Neurosci. Res. 18, 407-417.
19. Matute C., Sanchez-Gomez M. V., Martinez-Millan L. and Miledi R. (1997) Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proc. Natl Acad. Sci. USA 5, 8830-8835.
20. Matute C., Domercq M., Fogarty D. J., Pascual de Zulueta M. and Sanchez-Gomez M. V. (1999) On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS. Adv. Exp. Med. Biol. 468, 97-107.
21. Matute C., Alberdi E., Domercq M., Perez-Cerda F., Perez-Samartin A. and Sanchez-Gomez M. V. (2001) The link between excitotoxic oligodendroglial death and demyelinating diseases. Trends Neurosci. 24, 224-230.
22. McDonald J. W., Althomsons S. P., Hyrc K. L., Choi D. W. and Goldberg M. P. (1998a) Oligodendrocytes from forebrain are highly vulnerable to AMPA/ kainate receptor-mediated excitotoxicity. Nat. Med. 4, 291-297.
23. McDonald J. W., Levine J. M. and Qu Y. (1998b) Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity. Neuroreport 9, 2757-2762.
24. Oka A., Belliveau M. J., Rosemberg P. A. and Volpe J. J. (1993) Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J. Neurosci. 7, 357-368.
25. Patneau D. K., Vyklicky L. Jr and Mayer M. L. (1993) Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J. Neurosci. 13, 3496-3509.
26. Pitt D., Werner P. and Raine C. S. (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat. Med. 6, 67-70.
27. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C. and Bastianello S. (2003) 'Gender gap' in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 10, 95-97.
28. Puchalski R. B., Louis J. C., Brose N. et al. (1994) Selective RNA editing and subunit assembly of native glutamate receptors. Neuron 13, 131-147.
29. Sanchez-Gomez M. V. and Matute C. (1996) Activation of AMPA and kainate glutamate receptors impairs the viability of oligodendrocytes in vitro. Int. J. Dev. Biol. Suppl. 1, 187S-188S.
30. Sanchez-Gomez M. V. and Matute C. (1999) AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures. Neurobiol. Dis. 6, 475-485.
31. SPECTRIMS (Secondary progressive efficacy clinical trial of recombinant 1NFβ1a in multiple sclerosis study group) (2001) Randomized controlled trial of INFβ1a in secondary progressive multiple sclerosis: clinical results. Neurology 56, 1496-1504.
32. Smith T., Groom A., Zhu B. and Turski L. (2000) Autoimmune encephalomyelitis ameliorated by AMPA antagonists. Nat. Med. 6, 62-66.
33. Sommer B., Kohler M., Sprengel R. and Seeburg P. H. (1991) RNA editing in brain controls a determinant of ion flow in glutamategated channels. Cell 67, 11-19.
34. Steinhauser C. and Gallo V. (1996) News on glutamate receptors in glial cells. Trends Neurosci. 19, 339-345.
35. Verkhratsky A. and Steinhauser C. (2000) Ion channels in glial cells. Brain Res. Brain Res. Rev. 32, 380-412.
36. Voskuhl R. R. and Palaszynski K. (2001) Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7, 258-270.
37. Whitacre C. C., Reingold S. C. and O'Looney P. A. (1999) A gender gap in autoimmunity. Science 26, 1277-1278.
38. Yamada K. A. and Turetsky D. M. (1996) Allosteric interactions between cyclothiazide and AMPA/kainate receptor antagonists. Br. J. Pharmacol. 117, 1663-1672.